GOG 277: Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma Last updated on Apr 21, 2024 Previous GeDDiS Trial: Gemcitabine and docetaxel versus doxorubicin as first-line treatment sarcomas Next Sarcoma Trials
